Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Principles of Disease Surveillance

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The assetization of care? A comparative exploration of investor logic in healthcare systems in England, Canada, and the Netherlands.

Health economics, policy, and law·2026

Same author

Designing and delivering youth mental health services for young people, with young people: what works? A protocol for a realist eDelphi study on effective co-production.

BMJ open·2026

Same author

Referral pathways into the NHS Digital Weight Management Programme for musculoskeletal and perioperative patients: rapid process evaluation.

Health and social care delivery research·2026

Same author

Genomic characterization and SNP analysis connect respiratory infections caused by <i>Mycobacterium intracellulare</i> with a pool facility.

Microbial genomics·2025

Same author

Review of residential and nursing care home policies on safety incident reporting in England.

Journal of health services research & policy·2025

Same author

Perioperative Medicine for Older People Undergoing Surgery Scale Up (POPS-SUp): study protocol.

BJS open·2025

Search research articles

Related Experiment Video

Updated: May 16, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Tuberculosis notifications in Australia, 2008 and 2009.

Christina Barry¹, Justin Waring, Richard Stapledon

¹Vaccine Preventable Diseases Surveillance Section, Department of Health and Ageing, Canberra, Australian Capital Territory. christina.barry AT health.gov.au

Communicable Diseases Intelligence Quarterly Report

|November 17, 2012

Summary

This summary is machine-generated.

Tuberculosis (TB) incidence in Australia remained stable between 2008-2009, primarily affecting the overseas-born population. High treatment success rates were observed, emphasizing the need for continued surveillance.

Related Experiment Videos

Last Updated: May 16, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Area of Science:

Public Health
Infectious Disease Epidemiology

Background:

Tuberculosis (TB) surveillance in Australia relies on the National Notifiable Diseases Surveillance System.
TB incidence rates in Australia have remained relatively stable since 1986.

Purpose of the Study:

To analyze tuberculosis (TB) notifications and incidence in Australia for 2008 and 2009.
To identify high-risk populations and risk factors for TB infection.
To assess TB treatment outcomes and healthcare worker infections.

Main Methods:

Analysis of tuberculosis (TB) notification data from the National Notifiable Diseases Surveillance System for 2008 and 2009.
Calculation of TB incidence rates per 100,000 population, stratified by birthplace and Indigenous status.
Review of reported risk factors, healthcare worker cases, and treatment outcomes.

Main Results:

TB incidence was 5.6/100,000 in 2008 and 6.0/100,000 in 2009.
Over 85% of cases occurred in the overseas-born population; incidence was significantly higher in this group compared to Australian-born populations.
Household contact and residence in high-risk countries were key risk factors. Healthcare worker TB cases decreased, with no reported transmission in healthcare settings. Treatment success exceeded 95%.

Conclusions:

Tuberculosis (TB) in Australia disproportionately affects the overseas-born population, with stable incidence rates.
Effective TB control relies on robust surveillance, identification of at-risk groups, and early detection of trend reversals.
High treatment success rates indicate effective management strategies.